Skip to main content

Volume 3 Supplement 1

ESICM LIVES 2015

Impact of an inducement to give high doses of amikacin and gentamicin on serum concentrations in critically ill patients with severe sepsis

Introduction

Low first-dose peak serum concentrations of amikacin and gentamicin are reported in intensive care unit (ICU) patients.1

Objectives

The present study aimed at assessing the impact of giving high doses of amikacin (30 mg/kg) or gentamicin (8 mg/kg) in ICU patients with severe sepsis.

Methods

Single-center observational study. All ICU patients with clinical indication of aminoglycosides were eligible.ICU physicians were encouraged to administer maximal recommended doses of amikacin and gentamicin (30 and 8 mg/kg, respectively). The first and subsequent doses and corresponding peak plasma concentrations were recorded. Guideline targets for serum concentrations were used with ≥60 and ≥30 mg/L for amikacin and gentamicin, respectively. A target pharmacokinetic/pharmacodynamic (PK/PD) ratio of 10-times the minimal inhibitory concentration (10xMIC) was also measured.

Results

Sixty-three ICU patients (39 males, 68 ± 16 years, 75 ± 22 kg, 168 ± 8 cm, SAPS II = 43 ± 16) with severe sepsis and an indication for IV amikacin (n= 47) or gentamicin (n = 16), were included. Pulmonary, abdominal and urinary tract infections were diagnosed in 56 patients. Infection was confirmed in 37 (59%) patients. The target first-dose peak serum concentration was achieved in 37/63 patients (59%)(36/47 (77%) and 1/16 (6%) patient for amikacin and gentamicin, respectively). 59/63 (94%) patients achieved the PK/PD target using the MIC data that was available from 21 patients. However, the subsequent injection should be cancelled in nearly half of patients due to a too high trough, without renal function impairment.

Conclusions

30 mg/kg amikacin and 8 mg/kg gentamicin doses led to adequate peak serum concentrations in 59% patients using guideline targets.

Figure 1
figure 1

Amikacin peak concentrations after the first dose.

References

  1. de Montmollin E, Bouadma L, Gault N, Mourvillier B, Mariotte E, Chemam S, et al: Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimen. Intensive Care Med. 2014, 40 (7): 998-1005. 10.1007/s00134-014-3276-x.

    PubMed  Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Roger, C., Louart, B., Muller, L. et al. Impact of an inducement to give high doses of amikacin and gentamicin on serum concentrations in critically ill patients with severe sepsis. ICMx 3 (Suppl 1), A402 (2015). https://doi.org/10.1186/2197-425X-3-S1-A402

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/2197-425X-3-S1-A402

Keywords

  • Serum Concentration
  • Urinary Tract Infection
  • Minimal Inhibitory Concentration
  • Gentamicin
  • Severe Sepsis